Natriuretic peptides derived from pro-opiocortin.

Area of Science:

• Endocrinology
• Neuroscience
• Nephrology

Background:

• Natriuresis, the excretion of sodium by the kidneys, is crucial for maintaining fluid balance.
• Central nervous system (CNS) regulation and humoral factors are implicated in controlling natriuresis in response to various physiological stimuli.
• Adrenocorticotropic hormone (ACTH) and alpha-melanocyte-stimulating hormone (alpha MSH) share a common sequence, ACTH(4-10)/alpha MSH(4-10), with proposed natriuretic activity.

Purpose of the Study:

• To identify the specific peptide sequence responsible for natriuretic activity.
• To investigate the role of gamma-2 MSH, a peptide containing the ACTH(4-10)-like sequence, in regulating renal sodium excretion.
• To explore the potential contribution of gamma MSH peptides to CNS control of sodium balance.

Main Methods:

• Peptide synthesis and modification, including steric restriction by amino acid substitution (L-Phe to D-Phe).
• Administration of synthesized peptides to assess natriuretic effects.
• Dose-response analysis of gamma-2 MSH on renal sodium excretion.

Main Results:

• The natriuretic activity of ACTH and alpha MSH was localized to the common sequence ACTH(4-10)/alpha MSH(4-10).
• A modified peptide with steric restriction (D-Phe substitution) demonstrated superagonist activity.
• Gamma-2 MSH exhibited a dose-dependent natriuretic effect, with maximal activity observed between 0.64 and 64 pmole.
• Doses exceeding 128 pmole of gamma-2 MSH did not produce further significant effects on sodium excretion.

Conclusions:

• The ACTH(4-10)/alpha MSH(4-10) sequence is a key mediator of natriuresis.
• Gamma-2 MSH, acting via this sequence, plays a role in the central nervous system's regulation of renal sodium excretion.
• Regulated release of gamma MSH peptides may be a mechanism for maintaining sodium homeostasis.